Amylin Pharmaceuticals to Present at Nasdaq 20th Investor Program
November 30 2007 - 7:00AM
PR Newswire (US)
SAN DIEGO, Nov. 30 /PRNewswire-FirstCall/ -- Amylin
Pharmaceuticals, Inc. (NASDAQ:AMLN) will be presenting at the
Nasdaq 20th Investor Program in London on Thursday, December 6,
2007 at 7:15 a.m. PT / 3:15 p.m. GMT local time in the UK. Berthold
Lensker, Ph.D., Executive Director of European Operations, will be
providing a corporate overview of Amylin Pharmaceuticals. The live
presentation will be webcast, and a recording will be made
available following the event. The webcast and recording will be
accessible through Amylin's corporate website, located at
http://www.amylin.com/. To access the live webcast, please log on
to Amylin's site approximately fifteen minutes prior to the
presentation to register and download any necessary audio software.
More information about the Nasdaq 20th Investor Program is
available at: http://december.nasdaqconference.com/info.asp. About
Amylin Pharmaceuticals Amylin Pharmaceuticals is a
biopharmaceutical company committed to improving lives through the
discovery, development and commercialization of innovative
medicines. Amylin has developed and gained approval for two first-
in-class medicines for diabetes, SYMLIN(R) (pramlintide acetate)
injection and BYETTA(R) (exenatide) injection. Amylin's research
and development activities leverage the company's expertise in
metabolism to develop potential therapies to treat diabetes and
obesity. Amylin is located in San Diego, California with over 1,800
employees nationwide. Further information on Amylin Pharmaceuticals
is available at http://www.amylin.com/. DATASOURCE: Amylin
Pharmaceuticals, Inc. CONTACT: Alice Bahner Izzo, Executive
Director, Corporate Affairs of Amylin Pharmaceuticals, Inc.,
+1-858-552-2200, ext. 7272 Web site: http://www.amylin.com/
http://december.nasdaqconference.com/info.asp
Copyright
Amylin Pharmaceuticals, Inc. (MM) (NASDAQ:AMLN)
Historical Stock Chart
From Jun 2024 to Jul 2024
Amylin Pharmaceuticals, Inc. (MM) (NASDAQ:AMLN)
Historical Stock Chart
From Jul 2023 to Jul 2024